Vitru

Vitru ROCE

Delisted

The Return on Capital Employed (ROCE) of Vitru (VTRU) as of Oct 20, 2026 is 29.11 %. In the previous year, Return on Capital Employed (ROCE) was 17.87 % — a change of 62.93% (higher).

ROCE

29.11 %

YoY

62.93%

Last updated:

In 2023, Vitru's return on capital employed (ROCE) was 29.11 %, a 62.93% increase from the 17.87 % ROCE in the previous year.

The Vitru ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
7.12 BRL
Jan 1, 2019
4.94 BRL
Jan 1, 2020
14.08 BRL
Jan 1, 2021
17.78 BRL
Jan 1, 2022
17.87 BRL
Jan 1, 2023
29.11 BRL
The Vitru ROCE history
YEARROCEYoY
29.11 %+62.93%
17.87 %+0.52%
17.78 %+26.23%
14.08 %+185.03%
4.94 %-30.65%
7.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vitru Stock analysis

What does Vitru do? Vitru Ltd is a British company specializing in the production and sale of high-quality and innovative implants and medical devices. The company was founded in 2011 and is based in London. Its initial focus was on developing products for human body reconstruction, including implants for knees, hips, and shoulders, as well as products for tendon and ligament repair. Vitru produces high-quality products that meet the highest standards by using state-of-the-art technologies and materials. The company has quickly become a leading provider in this market and continues to expand its offerings and expertise. This includes not only the manufacturing of implants but also the development and production of instruments and procedures that enable more precise and efficient surgeries for doctors and surgeons. Vitru also offers products and services in the areas of phenotyping and genotyping, collecting data on a person's genetic characteristics and using that information for personalized medicine and diagnostics. Another business field of Vitru is 3D printing. By utilizing 3D printing technology, the company can rapidly manufacture products and better meet customer needs. Vitru offers a wide range of implants that can be customized to individual customer requirements. In this context, Vitru has also engaged in the production of masks and other facial protection products to contribute to the fight against the COVID-19 pandemic. Vitru's products are known for their high quality, durability, and functionality. They are distributed both in the UK and worldwide and are used in orthopedics, neurosurgery, and other medical specialties. The company has a clear mission to be a global leader in the development and manufacturing of medical devices and implants tailored to the needs of patients and surgeons. To fulfill this mission, Vitru collaborates closely with professionals in the fields of medicine and technology. The company also works closely with hospitals and research institutions to stay up to date with the latest developments in medicine and technology and incorporate them into its products. An example of this is the development of knee implants specifically designed for women to better accommodate their needs. Overall, Vitru has established itself as an important player in the medical technology industry and is committed to improving healthcare for patients worldwide. Vitru is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Vitru's Return on Capital Employed (ROCE)

Vitru's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Vitru's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Vitru's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Vitru’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Vitru stock

Return on Capital Employed (ROCE) of Vitru is 29.11 % in 2023.

Return on Capital Employed (ROCE) of Vitru changed from 17.87 % to 29.11 %, representing a 62.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Vitru since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Vitru with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Vitru

All Key Metrics — Vitru